Author

Michal Krupka

Palacký University OlomoucORCID 0000-0001-7795-5380Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alan StrungaiD· 1 shared David BednářiD· 1 shared Jan MičaniD· 1 shared Jan VítečekiD· 1 shared Jiřı́ DamborskýiD· 1 shared Kateřina Zachová· 1 shared Lenka SindlerovaiD· 1 shared Lukáš KubalaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alan StrungaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintJun 2, 2026

Biochemical and Immunological Properties of Engineered Low-Immunogenic Staphylokinases for Next-Generation Thrombolytic Therapy

Alan Strunga, Michaela Pešková, Michal Krupka…·Zbyněk Prokop

The paper compares biochemical and immunological properties of engineered low-immunogenic staphylokinase variants to identify the most promising for thrombolytic therapy.

DOI 10.64898/2026.01.04.697554

experimental assaydrug response / drug discovery